Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06112379
PHASE3

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer.

Official title: A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1902

Start Date

2023-11-14

Completion Date

2032-09-23

Last Updated

2026-10-21

Healthy Volunteers

No

Conditions

Interventions

DRUG

Dato-DXd

Experimental drug IV infusion

DRUG

Durvalumab

Experimental drug IV Infusion

DRUG

Pembrolizumab

IV Infusion Active comparator

DRUG

Doxorubicin

IV infusion Experimental/Active Comparator

DRUG

Epirubicin

IV Infusion Experimental/Active Comparator

DRUG

Cyclophosphamide

IV infusion Experimental/Active Comparator

DRUG

Paclitaxel

IV infusion Experimental/Active Comparator

DRUG

Carboplatin

IV infusion Experimental/Active Comparator

DRUG

Capecitabine

Tablet Oral route of administration Experimental/Active Comparator

DRUG

Olaparib

Tablet Oral route of administration Experimental/Active Comparator

Locations (283)

Research Site

Daphne, Alabama, United States

Research Site

Prescott, Arizona, United States

Research Site

Jonesboro, Arkansas, United States

Research Site

Rogers, Arkansas, United States

Research Site

Los Angeles, California, United States

Research Site

Santa Barbara, California, United States

Research Site

Santa Rosa, California, United States

Research Site

Torrance, California, United States

Research Site

Aurora, Colorado, United States

Research Site

Longmont, Colorado, United States

Research Site

Bridgeport, Connecticut, United States

Research Site

New Haven, Connecticut, United States

Research Site

Fort Myers, Florida, United States

Research Site

Jacksonville, Florida, United States

Research Site

St. Petersburg, Florida, United States

Research Site

West Palm Beach, Florida, United States

Research Site

Atlanta, Georgia, United States

Research Site

Des Moines, Iowa, United States

Research Site

Edgewood, Kentucky, United States

Research Site

Louisville, Kentucky, United States

Research Site

Baton Rouge, Louisiana, United States

Research Site

Annapolis, Maryland, United States

Research Site

Boston, Massachusetts, United States

Research Site

Grand Rapids, Michigan, United States

Research Site

Traverse City, Michigan, United States

Research Site

Burnsville, Minnesota, United States

Research Site

Minneapolis, Minnesota, United States

Research Site

Columbia, Missouri, United States

Research Site

Omaha, Nebraska, United States

Research Site

East Brunswick, New Jersey, United States

Research Site

New Brunswick, New Jersey, United States

Research Site

Santa Fe, New Mexico, United States

Research Site

New York, New York, United States

Research Site

Charlotte, North Carolina, United States

Research Site

Durham, North Carolina, United States

Research Site

Winston-Salem, North Carolina, United States

Research Site

Blue Ash, Ohio, United States

Research Site

Eugene, Oregon, United States

Research Site

Portland, Oregon, United States

Research Site

Philadelphia, Pennsylvania, United States

Research Site

Pittsburgh, Pennsylvania, United States

Research Site

Chattanooga, Tennessee, United States

Research Site

Nashville, Tennessee, United States

Research Site

Austin, Texas, United States

Research Site

Dallas, Texas, United States

Research Site

Dallas, Texas, United States

Research Site

Dallas, Texas, United States

Research Site

El Paso, Texas, United States

Research Site

Flower Mound, Texas, United States

Research Site

Fort Worth, Texas, United States

Research Site

Houston, Texas, United States

Research Site

San Antonio, Texas, United States

Research Site

Webster, Texas, United States

Research Site

Fairfax, Virginia, United States

Research Site

Norfolk, Virginia, United States

Research Site

Roanoke, Virginia, United States

Research Site

Winchester, Virginia, United States

Research Site

Tacoma, Washington, United States

Research Site

East Melbourne, Australia

Research Site

Feldkirch, Austria

Research Site

Innsbruck, Austria

Research Site

Linz, Austria

Research Site

Salzburg, Austria

Research Site

Antwerp, Belgium

Research Site

Brasschaat, Belgium

Research Site

Charleroi, Belgium

Research Site

Ghent, Belgium

Research Site

Leuven, Belgium

Research Site

Libramont-Chevigny, Belgium

Research Site

Brasília, Brazil

Research Site

Curitiba, Brazil

Research Site

Fortaleza, Brazil

Research Site

Londrina, Brazil

Research Site

Natal, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Ribeirão Preto, Brazil

Research Site

Santo André, Brazil

Research Site

São Paulo, Brazil

Research Site

Taubaté, Brazil

Research Site

Vitória, Brazil

Research Site

Shumen, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Calgary, Alberta, Canada

Research Site

Vancouver, British Columbia, Canada

Research Site

Barrie, Ontario, Canada

Research Site

London, Ontario, Canada

Research Site

Oshawa, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Lévis, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Saint-Jérôme, Quebec, Canada

Research Site

Sherbrooke, Quebec, Canada

Research Site

Montreal, Canada

Research Site

Ottawa, Canada

Research Site

Beijing, China

Research Site

Bengbu, China

And 183 more locations on ClinicalTrials.gov